Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07309848 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

Study acronym: OPTIMIZEDOAC
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study looks at patients with hip fractures who are taking direct oral anticoagulants (DOACs), a type of blood thinner. In many hospitals, surgery for these patients is delayed because of concerns about bleeding, but waiting longer can also increase risks such as complications and longer hospital stays. The purpose of this study is to find out whether operating within 24 hours is as safe as delaying surgery beyond 24 hours. Specifically, the investigators want to know if early surgery does not lead to a higher need for blood transfusions compared to delayed surgery.
Trial Details
NCT Number NCT07309848
Lead Sponsor St. Antonius Hospital
Conditions
(from sponsor)		 Blood Transfusion, Hip Fracture Surgeries, Geriatric, Bleeding Complications, Bleeding as Surgical Complication (Treatment), Bleeding, Blood Transfusions, Blood Transfusion Complication +1 more
Related terms Hemorrhage, Hip Fractures, Transfusion Reaction
Enrollment 374 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov